Filing Flows › CareDx (CDNA) › Guidance history
CareDx (CDNA) guidance history: what it guided and what it reported
CareDx gave guidance in 12 earnings releases on file since Oct 15, 2024. Of 2 guided periods since reported, it met or beat its own guidance twice (100%). Revenue: 2 of 2, on average +1.5% against the guided midpoint. Its releases raised guidance 5 times and lowered it 0 times.
Revenue
Met or beat 2 of 2 periods (2 above, 0 within, 0 below).
| Period | Guided (and how it moved) | Reported | Result | vs midpoint |
|---|---|---|---|---|
| FY2026 | $420M–$444M (Feb 24, 2026) → reaffirmed $420M–$444M (Feb 25, 2026) → raised $447M–$465M (Apr 28, 2026) → raised $490M–$500M (Jul 30, 2026) → raised $520M–$530M (Oct 29, 2026) | — | to be reported | — |
| FY2025 | $365M–$375M (Feb 26, 2025) → reaffirmed $365M–$375M (Apr 30, 2025) → reaffirmed $367M–$373M (Aug 6, 2025) → raised $372M–$376M (Nov 4, 2025) | $380M | above the range | +1.6% |
| FY2024 | $327M–$331M (Nov 4, 2024) | $334M | above the range | +1.4% |
Adjusted revenue
The guide is on an adjusted basis that the GAAP statements do not show, so there is no reported figure to hold it to.
| Period | Guided (and how it moved) | Reported | Result | vs midpoint |
|---|---|---|---|---|
| FY2024 | $327M–$331M (Nov 4, 2024) | — | — | — |
Adjusted gross margin
The guide is on an adjusted basis that the GAAP statements do not show, so there is no reported figure to hold it to.
| Period | Guided (and how it moved) | Reported | Result | vs midpoint |
|---|---|---|---|---|
| FY2024 | 69.0% (Nov 4, 2024) | — | — | — |
Adjusted EBITDA
The guide is on an adjusted basis that the GAAP statements do not show, so there is no reported figure to hold it to.
| Period | Guided (and how it moved) | Reported | Result | vs midpoint |
|---|---|---|---|---|
| FY2026 | $30.0M–$45.0M (Feb 24, 2026) → reaffirmed $30.0M–$45.0M (Feb 25, 2026) → raised $43.0M–$57.0M (Apr 28, 2026) → raised $66.0M–$78.0M (Jul 30, 2026) → raised $90.0M–$100M (Oct 29, 2026) | — | to be reported | — |
| FY2027 | $100M (Apr 30, 2025) | — | to be reported | — |
| FY2025 | $8.0M–$9.0M (Jan 13, 2025) → raised $29.0M–$33.0M (Feb 26, 2025) → reaffirmed $29.0M–$33.0M (Apr 30, 2025) → reaffirmed $29.0M–$33.0M (Aug 6, 2025) → raised $35.0M–$39.0M (Nov 4, 2025) | — | — | — |
| FY2024 | $18.0M–$22.0M (Nov 4, 2024) | — | — | — |
The latest quarter
CareDx, Q3 2026: revenue $139M (+39% year over year), operating margin 5.8%, net earnings $19.3M, operating cash flow $12.7M. The chart follows the revenue to costs, profit and cash.
Questions
Does CareDx beat its guidance?
CareDx gave guidance in 12 earnings releases on file since Oct 15, 2024. Of 2 guided periods since reported, it met or beat its own guidance twice (100%). Revenue: 2 of 2, on average +1.5% against the guided midpoint.
How often does CareDx raise guidance?
Its earnings releases raised guidance 5 times and lowered it 0 times since Oct 15, 2024.
Each guided period is held to the last guidance given before its figures were reported; a single figure counts as in line within 1% (0.25 pts for a rate). Reported figures are GAAP, from the company's filings; adjusted guidance shows its moves only.